Skip to main content
. 2009 Mar 2;27(14):2363–2373. doi: 10.1200/JCO.2008.21.1441

Table 1.

Risky Health Behaviors and Medical Care Among Survivors of Childhood Cancer by Various Types of Cancer Therapy Associated With an Increased Risk of Long-Term Morbidity

Cancer Therapy Risky Health Behaviors* (%)
Medical Care (%)
Current Smoker Risky Drinking Physically Inactive No Medical Care General Medical Care General Survivor-Focused Care Risk-Based Survivor-Focused Care
Total cohort 14.3 14.5 23.9 11.2 57.3 13.7 17.8
Chest radiation therapy
    Yes 13.0 14.0 20.8 7.9 49.3 14.7 28.0
    No 14.8 14.8 24.9 12.0 59.4 13.3 15.3
Anthracyclines ≥ 300 mg/m2
    Yes 12.1 14.1 23.0 11.3 55.4 13.1 20.2
    No 14.7 14.7 24.1 11.1 57.8 13.7 17.3
Pulmonary toxic therapy
    Yes 11.6 12.9 25.8 8.4 51.9 15.5 24.1
    No 14.7 14.9 23.6 11.5 58.0 13.4 17.0
Alkylating agent therapy
    Yes 12.4 14.4 22.9 10.6 52.2 14.6 22.5
    No 15.0 14.9 24.5 11.5 59.5 13.1 15.9
*

Includes only survivors 18 years or older who responded; current smoker and physically inactive sample size is 6,244 participants who responded to the 2003 Childhood Cancer Survivor Study (CCSS) survey; risky drinking sample size is 8,988 participants who responded to the baseline CCSS survey.

Includes survivors of any age who completed the 2003 CCSS survey; sample size is 8,522 participants.

Pulmonary toxic therapies include any of the following: bleomycin, busulfan, carmustine, lomustine.